[Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and

Related Experiment Video

Updated: Jul 15, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

Franciska Erdo1, Ivo R Buschmann

  • 1IVAX Gyógyszerkutató Intézet Kft., Farmakológia Osztály, Budapest. erdof2002@yahoo.de

Orvosi Hetilap
|April 4, 2007
PubMed

Insights

Arteriogenesis is the body's natural way to reroute blood flow through existing arteries to compensate for blockages. Stimulating this process shows promise for treating chronic artery diseases.

Area of Science:

  • Cardiovascular Biology
  • Vascular Medicine
  • Regenerative Medicine

Context:

  • Arteriogenesis is a natural compensation mechanism for tissue hypoperfusion caused by arterial stenosis or occlusion.
  • Chronic artery diseases, including coronary heart disease, peripheral artery disease, and cerebrovascular disease, have been extensively studied for their roles in angiogenesis and arteriogenesis.
  • Understanding the cellular and molecular mechanisms of collateral artery development is crucial for therapeutic interventions.

Purpose:

  • To review the mechanisms of arteriogenesis and present experimental data on spontaneous and stimulated collateral artery growth.
  • To provide an overview of arteriogenesis as a potential therapeutic approach for chronic artery diseases.
  • To highlight key findings from in vivo and ex vivo studies on collateral vessel remodeling.

Summary:

  • Arteriogenesis enhances blood distribution through pre-existent collateral arteries to counteract tissue hypoperfusion.
  • Circulating monocytes, endothelial cells, and smooth muscle cells play vital roles in the remodeling of collateral blood vessels.
  • Stimulation of arteriogenesis using chemokines and growth factors has shown promising preclinical results, including improved collateral conductance and reduced infarct size.

Impact:

  • Preclinical studies demonstrate that stimulating arteriogenesis can improve functional parameters in conditions like myocardial ischemia and hemodynamic stroke.
  • Therapeutic strategies targeting arteriogenesis offer a promising new avenue for treating chronic artery diseases.
  • Further research is needed to address optimal delivery, dosage, timing, and follow-up for human investigations.

More Related Videos

Development of a Murine Model for Femoral Artery Anastomotic Stenosis05:42

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Published on: April 18, 2025

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...